3 results
Approved WMOCompleted
see protocol summary
Approved WMOCompleted
Evaluate the effect of tedalinab on ECG parameters, CNS Function and Pain Perception in Healthy Subjects.
Approved WMORecruiting
The hypothesis is that the amivantamab and lazertinib combination (Arm A) will demonstrate superior PFS compared with single-agent osimertinib (Arm B).